Menu
GeneBe

FBP1

fructose-bisphosphatase 1, the group of Fructose-1,6-bisphosphatases

Basic information

Region (hg38): 9:94603132-94640249

Previous symbols: [ "FBP" ]

Links

ENSG00000165140NCBI:2203OMIM:611570HGNC:3606Uniprot:P09467AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • fructose-1,6-bisphosphatase deficiency (Definitive), mode of inheritance: AR
  • fructose-1,6-bisphosphatase deficiency (Strong), mode of inheritance: AR
  • fructose-1,6-bisphosphatase deficiency (Strong), mode of inheritance: AR
  • fructose-1,6-bisphosphatase deficiency (Strong), mode of inheritance: AR
  • fructose-1,6-bisphosphatase deficiency (Supportive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Fructose-1,6-bisphosphatase deficiencyARBiochemicalThe condition may be lethal in the perinatal period, but prompt recognition and treatment of lactic acidosis and hypoglycemia (eg, with IV/oral glucose, sodium bicarbonate) can be effectiveBiochemical4193749; 4335192; 4341454; 4341015; 175754; 2347355; 1995492; 9382095; 12126934; 17705024; 19259699; 20096900; 22158280

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FBP1 gene.

  • Fructose-biphosphatase deficiency (159 variants)
  • not provided (45 variants)
  • not specified (29 variants)
  • Inborn genetic diseases (9 variants)
  • Abnormality of acid-base homeostasis;Impaired gluconeogenesis (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBP1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
37
clinvar
3
clinvar
41
missense
2
clinvar
10
clinvar
38
clinvar
4
clinvar
1
clinvar
55
nonsense
4
clinvar
1
clinvar
5
start loss
1
clinvar
1
frameshift
9
clinvar
3
clinvar
1
clinvar
13
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
3
clinvar
1
clinvar
4
splice region
1
4
7
1
13
non coding
8
clinvar
19
clinvar
11
clinvar
38
Total 19 16 48 60 15

Highest pathogenic variant AF is 0.0000197

Variants in FBP1

This is a list of pathogenic ClinVar variants found in the FBP1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
9-94603132-CT-C Fructose-biphosphatase deficiency Benign/Likely benign (Jun 29, 2018)367554
9-94603229-G-A Fructose-biphosphatase deficiency Uncertain significance (Jan 13, 2018)913846
9-94603254-G-A Fructose-biphosphatase deficiency Uncertain significance (Jan 13, 2018)913847
9-94603260-A-C Fructose-biphosphatase deficiency Conflicting classifications of pathogenicity (Oct 27, 2020)913848
9-94603360-G-A not specified • Fructose-biphosphatase deficiency Benign (Aug 10, 2021)256318
9-94603377-G-A not specified Likely benign (Apr 04, 2016)384873
9-94603385-TG-T Fructose-biphosphatase deficiency Uncertain significance (Sep 07, 2022)2153994
9-94603389-C-A Inborn genetic diseases Uncertain significance (Jul 06, 2021)2234792
9-94603390-A-G Fructose-biphosphatase deficiency Likely benign (May 19, 2023)2865811
9-94603401-C-T Fructose-biphosphatase deficiency Uncertain significance (Jan 12, 2018)976589
9-94603412-A-G Fructose-biphosphatase deficiency Pathogenic/Likely pathogenic (Dec 06, 2023)1685318
9-94603413-G-T Fructose-biphosphatase deficiency Uncertain significance (Feb 05, 2022)1482254
9-94603414-G-A Fructose-biphosphatase deficiency Likely benign (Jul 07, 2023)2832053
9-94603417-C-T Fructose-biphosphatase deficiency Likely benign (Dec 04, 2023)2991076
9-94603420-G-A Fructose-biphosphatase deficiency Likely benign (Oct 19, 2023)739375
9-94603420-G-C Fructose-biphosphatase deficiency Likely benign (Dec 18, 2023)1950138
9-94603421-A-G Fructose-biphosphatase deficiency Uncertain significance (Oct 14, 2021)658878
9-94603422-G-C not specified Likely benign (Mar 06, 2014)214361
9-94603426-G-A Fructose-biphosphatase deficiency Likely benign (Jun 03, 2023)2995308
9-94603427-T-C Fructose-biphosphatase deficiency Uncertain significance (Dec 27, 2019)859120
9-94603428-C-T Fructose-biphosphatase deficiency Uncertain significance (Dec 20, 2021)214368
9-94603429-G-A Fructose-biphosphatase deficiency Likely benign (Sep 20, 2023)2725139
9-94603431-CG-C Fructose-biphosphatase deficiency Conflicting classifications of pathogenicity (Jan 16, 2024)548499
9-94603432-G-A Fructose-biphosphatase deficiency Likely benign (Dec 26, 2023)3017109
9-94603436-G-GA Fructose-biphosphatase deficiency Pathogenic (May 27, 2023)2809502

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FBP1protein_codingprotein_codingENST00000415431 737117
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.07910.9111257380101257480.0000398
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.7401701990.8530.00001102189
Missense in Polyphen5073.9210.67639787
Synonymous-1.4510083.21.200.00000532673
Loss of Function2.25412.70.3165.40e-7174

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.0001140.000109
Finnish0.000.00
European (Non-Finnish)0.00004430.0000439
Middle Eastern0.0001140.000109
South Asian0.0001310.0000980
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain. {ECO:0000269|PubMed:16497803, ECO:0000269|PubMed:18375435, ECO:0000269|PubMed:22517657}.;
Disease
DISEASE: Fructose-1,6-bisphosphatase deficiency (FBP1D) [MIM:229700]: An autosomal recessive metabolic disorder characterized by impaired gluconeogenesis, and episodes of hypoglycemia and metabolic acidosis that can be lethal in newborn infants or young children. {ECO:0000269|PubMed:12126934, ECO:0000269|PubMed:25601412, ECO:0000269|PubMed:9382095}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Glycolysis / Gluconeogenesis - Homo sapiens (human);Fructose and mannose metabolism - Homo sapiens (human);AMPK signaling pathway - Homo sapiens (human);Glucagon signaling pathway - Homo sapiens (human);Pentose phosphate pathway - Homo sapiens (human);Insulin signaling pathway - Homo sapiens (human);Pentose Phosphate Pathway;Fructose intolerance, hereditary;Gluconeogenesis;Glycogenosis, Type IA. Von gierke disease;Glycogenosis, Type IC;Glucose-6-phosphate dehydrogenase deficiency;Ribose-5-phosphate isomerase deficiency;Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease;Transaldolase deficiency;Fructose and Mannose Degradation;Triosephosphate isomerase;Fructose-1,6-diphosphatase deficiency;Fructosuria;Phosphoenolpyruvate carboxykinase deficiency 1 (PEPCK1);Glycogenosis, Type IB;Angiopoietin Like Protein 8 Regulatory Pathway;Glycolysis and Gluconeogenesis;Metabolism of carbohydrates;Fructose Mannose metabolism;Glycolysis Gluconeogenesis;Metabolism;Pentose phosphate cycle;gluconeogenesis;Gluconeogenesis;Glucose metabolism (Consensus)

Recessive Scores

pRec
0.507

Intolerance Scores

loftool
0.460
rvis_EVS
-0.01
rvis_percentile_EVS
53.51

Haploinsufficiency Scores

pHI
0.374
hipred
Y
hipred_score
0.754
ghis
0.425

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.990

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fbp1
Phenotype

Gene ontology

Biological process
negative regulation of transcription by RNA polymerase II;sucrose biosynthetic process;fructose metabolic process;fructose 6-phosphate metabolic process;gluconeogenesis;regulation of gluconeogenesis;dephosphorylation;negative regulation of cell growth;fructose 1,6-bisphosphate metabolic process;cellular response to drug;negative regulation of glycolytic process;negative regulation of Ras protein signal transduction;protein homotetramerization;cellular response to magnesium ion
Cellular component
nucleus;cytoplasm;cytosol;extracellular exosome
Molecular function
protein binding;AMP binding;fructose 1,6-bisphosphate 1-phosphatase activity;identical protein binding;metal ion binding;monosaccharide binding